Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Radius Loading in Primary Hyperparathyroidism [NA]
A Columbia University–sponsored clinical trial evaluating radius loading in primary hyperparathyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis [Phase 4]
Phase 4 clinical trial update reporting completion of a conversion study evaluating switching from Hectorol Injection to Hectorol Capsules i…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Primary Hyperparathyroidism: Non-classical Manifestations
A completed clinical trial studying non-classical manifestations of primary hyperparathyroidism. The sponsor is Columbia University.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis [Phase 1]
Phase 1 trial of KHK7580 for secondary hyperparathyroidism in peritoneal dialysis patients has completed.
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating the early effect of Vitamin D in primary hyperparathyroidism has been withdrawn. The study relates …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients [Phase 4]
Phase 4 trial evaluating mineral metabolism and vascular effects of Vitamin D therapy in kidney transplant patients; the study was terminate…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate [Phase 4]
This Phase 4 trial update examines the use of strontium ranelate as systemic treatment after surgical management of primary hyperparathyroid…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients [Phase 4]
A Phase 4 clinical trial update evaluating cinacalcet for secondary hyperparathyroidism in haemodialysis patients; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism
A completed clinical trial update studying paricalcitol, a selective vitamin D receptor activator, for prevention and treatment of secondary…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions [Phase 1]
A Phase 1 bioequivalence study of paricalcitol 4 mcg capsules under fasting conditions in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice
This clinical trial update reports long-term outcomes of treating chronic kidney disease patients with paricalcitol in German and Austrian c…
-
FDA approval · 2014-12-12FDA Approved: CALCITRIOL — Original Application (Chartwell RX, LLC)
FDA approved Calcitriol capsules (0.25 mcg and 0.5 mcg) from Chartwell RX, LLC through an Original Application, granting a generic version o…
-
CLINICAL_TRIALS withdrawal · 2014-12-05Clinical Trial Update: One Week Comparison Study of PTH and PTHrP Infusions [Phase 1]
A Phase 1 trial evaluating infusions of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) for osteoporosis and relat…
-
FDA approval · 2014-11-18FDA Approved: PARICALCITOL — Original Application (West-Ward Pharmaceuticals Corp)
FDA approved paricalcitol under an original NDA from West-Ward Pharmaceuticals Corp for the management of secondary hyperparathyroidism in a…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease [Phase 2]
Phase 2 safety study of CTA018 injection for Stage 5 chronic kidney disease has completed. The trial targeted patients with secondary hyperp…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis [Phase 4]
Phase 4 trial evaluating cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis was terminated.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets [Phase 3]
Phase 3 trial investigating paricalcitol to lower parathyroid hormone in familial hypophosphatemic rickets completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects [Phase 1]
A Phase 1 pharmacokinetics and safety pilot study evaluating single-dose oral and intravenous CTAP101 in stage 3–4 chronic kidney disease ha…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) [Phase 1]
This Phase 1 trial compares intravenous CTAP201 with doxercalciferol (Hectorol) in subjects with chronic kidney disease and secondary hyperp…
-
CLINICAL_TRIALS withdrawal · 2014-09-22Clinical Trial Update: Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) [Phase 2]
A Phase 2 trial of Lunacalcipol (CTA018) for chronic kidney disease stage 5 with secondary hyperparathyroidism has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)
A completed clinical trial evaluated Zemplar capsules (paricalcitol) for the treatment of secondary hyperparathyroidism in chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) [Phase 4]
Phase 4 trial comparing paricalcitol to calcitriol for efficacy and safety in stage 3/4 chronic kidney disease with secondary hyperparathyro…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease [Phase 3]
A phase 3 study evaluating sevelamer for secondary hyperparathyroidism in chronic kidney disease has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous
ClinicalTrials.gov update reports a quality-of-life study in Greek hemodialysis patients treated with Zemplar Intravenous (paricalcitol) for…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density [Phase 4]
Phase 4 clinical trial in Jerusalem area evaluating vitamin D status in men and its relationship to parathyroid hormone levels and bone mine…